FMC Corp. stock falls to fresh 52-week low as specialty chemicals weaken

FMC Corp. stock (ISIN US3024913036) is trading near the bottom of its recent range, with the shares hitting a new 52-week low of USD 9.94 during the session tied to September 18, 2026, as specialty chemicals names remain under pressure and investors reassess earnings and margin recovery prospects.

Stock slides to 52-week low

According to Investing.com on September 18, 2026, FMC Corp. shares reached a 52-week low intraday at USD 9.94, only a fraction below the prior 52-week trough of USD 9.95, underscoring how far the stock has fallen over the past year.

Regional editions of Investing.com Brazil and Investing.com France similarly reported the 52-week low at USD 9.94 for FMC Corp. shares on September 18, 2026, confirming the technical break to a new low.

An overview from StrongBuyAnalytics generated on September 18, 2026, lists a current FMC share price of USD 9.91, indicating that the stock is trading marginally below the intraday low reported earlier in the day and reinforcing the impression of persistent selling pressure around the USD 10 mark.

Valuation gap and sector context

Synthetic valuation work points to a notable gap between market pricing and intrinsic estimates. A separate analysis cited by Simply Wall St on September 18, 2026, describes FMC as trading around USD 10.20 against a widely referenced fair value estimate of about USD 13.52, implying the shares are roughly USD 3.32, or about 24.6 percent, below that fair value yardstick.

Sector commentary from Indy Finance on September 18, 2026, highlights that FMC Corporation shares touched USD 9.94 in the same session in which UBS reduced its price target on Element Solutions, a move interpreted as part of wider pressure across specialty chemicals and agricultural inputs.

According to Investing.com Korea on September 18, 2026, FMC Corp. is trading at a market capitalization of roughly USD 1.26 billion alongside the 52-week low print at USD 9.94, showing how far the company’s equity value has compressed compared with earlier years when the stock commanded a much larger market cap.

Earnings repair remains the key narrative

Recent valuation discussions, as summarized by Simply Wall St on September 18, 2026, emphasize that the implied fair value already assumes meaningful repair in earnings, margins and cash flow over the next several years, particularly as FMC advances its pipeline of RNA-based bioinsecticides and related crop protection products.

For investors, the fact that FMC Corp. stock trades about one quarter below certain fair value estimates on September 18, 2026, while simultaneously marking a fresh 52-week low, underlines both the potential upside in a successful earnings normalization scenario and the risk that margin recovery or volume growth may disappoint relative to those assumptions.

The same evaluations noted by Simply Wall St indicate that current pricing already embeds expectations of improved profitability, suggesting that any further negative surprises in earnings or free cash flow could justify the present discount and potentially extend the period during which the stock trades near the bottom of its 52-week range.

FMC Corp. stock at the close

Per the September 18, 2026 snapshot from StrongBuyAnalytics, FMC Corp. stock last traded around USD 9.91 on its primary listing in New York, with the earlier intraday move to a 52-week low of USD 9.94 leaving the shares close to that low and keeping the company’s market capitalization near USD 1.26 billion as of the same date.

More news and analyses on FMC Corp. stock